Gerhard Schrader: Father of the Nerve Agents — The Collaborative on Health and the Environment
The problem with organophosphates, as well as carbamates (another class of insecticide), is that they affect an important neurotransmitter common to both healthandenvironment.org/environmental-…
insects and mammals.
This neurotransmitter, acetylcholine, is essential for nerve cells to be able to communicate with each other.
In 1867, Adolf von Baeyer resolved the structures of choline and acetylcholine and synthetized them both, referring to the latter as
"acetylneurin" in the study. Choline is a precursor for acetylcholine. This is why Frederick Walker Mott and William Dobinson Halliburton noted in 1899 that choline injections decreased the blood pressure of animals.
Baeyer was born in Berlin as the son of the noted geodesist
and lieutenant-general in the Royal Prussian Army Johann Jacob Baeyer and his wife Eugenie Baeyer née Hitzig (1807–1843).
Numerous venoms and toxins produced by plants, animals, and bacteria, as well as chemical nerve agents such as Sarin, cause harm by inactivating or
hyperactivating muscles through their influences on the neuromuscular junction.
It remains unclear why Baeyer chose to name the compound that he discovered "barbituric acid".
Barbituric acid is the parent compound of barbiturate drugs, although barbituric acid itself is not
pharmacologically active.
Sodium thiopental is an ultra-short-acting barbiturate that is marketed under the name Sodium Pentothal. It is often mistaken for "truth serum", or sodium amytal, an intermediate-acting barbiturate that is used for sedation and to treat insomnia, but
was also used in so-called sodium amytal "interviews" where the person being questioned would be much more likely to provide the truth whilst under the influence of this drug.
An artillery officer is said to have christened the new substance by amalgamating Barbara with urea.
Another story was barbiturate was invented on the feast day of St. Barbara. Another story holds that Baeyer synthesized the substance from the collected urine of a Munich waitress named Barbara. No substance of medical value was discovered, however, until 1903 when two German
scientists working at Bayer, Emil Fischer and Joseph von Mering, discovered that barbital was very effective in putting dogs to sleep.
Barbital was then marketed by Bayer under the trade name Veronal.
Japanese writer Ryūnosuke Akutagawa deliberately overdosed on the drug in
1927, as did Un Chien Andalou actor Pierre Batcheff in 1932, Austrian writer Stefan Zweig in 1942 and Greek musician Attik in 1944. During The Holocaust, many Jewish residents of Berlin, Dresden, Wiesbaden and other German cities used Veronal to commit suicide to avoid
deportation to concentration camps by the Nazi Regime. Alfred Kerr German theatre critic and essayist on a trip to Germany after WWII, suffered a stroke, and decided to end his own life via an overdose of Veronal, procured for him by his wife
In the D. H. Lawrence story, The
Lovely Lady, the titular character dies from a self-administered overdose.
Barbital, under the name of "Veronal", has been used as a plot device in the author Agatha Christie's murder mysteries.
Towards the end of his life, Akutagawa began suffering from visual hallucinations
and anxiety over the fear that he had inherited his mother's mental disorder. In 1927 he survived a suicide attempt, together with a friend of his wife. He later died of suicide after taking an overdose of Veronal, which had been given to him by Saito Mokichi on 24 July of the
same year.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
BORIS NIKOLIC, M.D.
Managing Director
Dr. Nikolic is a physician and investor who previously served as chief advisor for science and technology to Bill Gates, leading select for-profit and not-for-profit investment activities. biomaticscapital.com/team/
His investments spanned the life science, information technology and health care sectors, including companies such as Foundation Medicine, ResearchGate, Schrodinger and Nimbus Therapeutics.
Dr. Nikolic completed postdoctoral training in transplantation immunology at Harvard
Medical School and served as an assistant professor of medicine at Massachusetts General Hospital/Harvard Medical School. He has authored more than 70 articles, patents and patent applications, and has co-founded several biotechnology companies that have since been acquired. Dr.
ZeniMax was founded in 1999 by Bethesda Softworks founder Christopher Weaver and Robert A. Altman. The name is a portmanteau of "zenith" and "maximum". en.wikipedia.org/wiki/ZeniMax_M…
The main front company for JMWAVE was "Zenith Technical Enterprises, Inc." In addition, about 300 to 400 other front companies were created throughout South Florida with a large range of "safe houses", cover businesses and other properties.
On January 29, 1984, Altman married
Wonder Woman actress Lynda Carter.
Altman practiced law for many years in Washington, D.C. as a partner of Clark Clifford, a former United States Secretary of Defense in the law firm of Clifford and Warnke.
From 1978 to 1982, Altman and Clifford represented a group of wealthy
In 1928, Amadeo Giannini, born in California to Italian immigrant parents, formed a holding company, the Transamerica Corporation, to consolidate his existing financial ventures, which began business with en.wikipedia.org/wiki/First_Int…
$1,100,000,000 in assets and both banking and non-banking activities. From the 1930s through the mid-1950s, Transamerica made a number of acquisitions of banks and other financial corporations throughout the western United States, creating the framework for the later First
Interstate system.
In 1953, regulators succeeded in forcing the separation of Transamerica Corporation and Bank of America under the Clayton Antitrust Act.
During the 1960s, 1970s, and 1980s Western Bancorporation operated in California under the UCB brand. In the early 1970s,
Nerve agent - Wikipedia
This first class of nerve agents, the G-series, was accidentally discovered in Germany on December 23, 1936, by a research team headed by Gerhard Schrader working for IG Farben. Since 1934, Schrader had been working in a laboratory en.wikipedia.org/wiki/Nerve_age…
in Leverkusen to develop new types of insecticides for IG Farben. While working toward his goal of improved insecticide, Schrader experimented with numerous compounds, eventually leading to the preparation of Tabun.
Schrader discovered two more organophosphate nerve agents, and
a fourth after the war:
•Tabun (1936)
•Sarin (1938)
•Soman (1944)
•Cyclosarin (1949)
Sarin was discovered by Schrader and his team in 1938 and named in honor of its discoverers: Gerhard Schrader, Otto Ambros, Gerhard Ritter [de], and Hans-Jürgen von der Linde.
Robert Peter Kadlec is an American physician and career officer in the United States Air Force who served as Assistant Secretary of Health and Human Services (Preparedness and Response) from August 2017 until January 2021. en.wikipedia.org/wiki/Robert_Ka…
The Office of Public Health Emergency Preparedness was established in June 2002 at the request of Tommy Thompson.
Its scope of activity included preparedness for bioterrorism, chemical and nuclear attack, mass evacuation and decontamination.
The first head of OPHEP was Donald
Henderson, credited with having previously eradicated Smallpox. Soon Jerry Hauer, a veteran public health expert, took over as director, with Henderson taking a different role in the department. Hauer was removed from the job primarily for conflicts he had with Scooter Libby
The Defense Threat Reduction Agency (DTRA) is an agency within the United States Department of Defense (DoD) and is the official Combat Support Agency for countering weapons of mass destruction (WMD; chemical, en.wikipedia.org/wiki/Defense_T…
biological, radiological, nuclear, and high explosives). According to the agency's Strategic Plan for Fiscal Years 2018 to 2022, the DTRA mission "enables DoD and the U.S. Government to prepare for and combat weapons of mass destruction and improvised threats and to ensure
nuclear deterrence." The agency is headquartered in Fort Belvoir, Virginia.
DTRA was officially established on October 1, 1998, as a result of the 1997 Defense Reform Initiative, by consolidating several DoD organizations, including the Defense Special Weapons Agency (successor